Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Quantitative Proteomics: A Major Piece in the Precision Medicine Puzzle

Posted on December 22nd, 2017 by in Pharma R&D

Our genetic make-up, where we live and how we live, are all important factors to consider when we are dealing with disease. For a very long time, medicine has mostly been designed to treat the sickness without much thought to the individual who has it. Continue reading “Quantitative Proteomics: A Major Piece in the Precision Medicine Puzzle” »

Delivering the Right Therapy to the Right Patient with ADCs

Posted on August 11th, 2017 by in Pharma R&D

One of the most powerful tools in the fight against cancer has become the patient’s very own immune system. Among the many approaches that researchers are exploring is the use of antibody-drug conjugates (ADCs) Continue reading “Delivering the Right Therapy to the Right Patient with ADCs” »

Is a new Alzheimer’s disease drug in the offing?

Posted on September 23rd, 2016 by in Pharma R&D

A high profile paper describing a prospective new therapy for Alzheimer’s disease (AD) was being shared around the internet recently. The paper, “The antibody aducanumab reduces Ab plaques in Alzheimer’s disease,” authored by Sevigny et al., was published on-line in Nature (Sevigny et al., 2016) and describes the preclinical and early clinical development of aducanumab, Continue reading “Is a new Alzheimer’s disease drug in the offing?” »

Impact of Precision Medicine and Genomics on Patient Treatment

Posted on August 26th, 2016 by in Chemistry

In January of 2015, President Barack Obama launched the Precision Medicine Initiative, which brought to the forefront the growing understanding and need for individually tailored and customized treatments for patients.

Continue reading “Impact of Precision Medicine and Genomics on Patient Treatment” »

  1. 1
  2. 2